Global Intravenous Solutions (Colloids) Market Growth 2025-2031

Global Intravenous Solutions (Colloids) Market Growth 2025-2031

The global Intravenous Solutions (Colloids) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.

LP Information, Inc. (LPI) ' newest research report, the “Intravenous Solutions (Colloids) Industry Forecast” looks at past sales and reviews total world Intravenous Solutions (Colloids) sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Solutions (Colloids) sales for 2025 through 2031. With Intravenous Solutions (Colloids) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Solutions (Colloids) industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Solutions (Colloids) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Solutions (Colloids) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous Solutions (Colloids) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Solutions (Colloids) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Solutions (Colloids).

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions (Colloids) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Segmentation by Application:
Hospital and Clinics
Ambulatory
Home Care

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravenous Solutions (Colloids) market?

What factors are driving Intravenous Solutions (Colloids) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravenous Solutions (Colloids) market opportunities vary by end market size?

How does Intravenous Solutions (Colloids) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.